Senior Notes Offering, Awards, Financial Results, and New Board Members - Analyst Notes on Monsanto, CF Industries, Huntsman, FMC and The Scotts Miracle-Gro

NEW YORK, June 6, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Monsanto Co. (NYSE: MON), CF Industries Holdings, Inc. (NYSE: CF), Huntsman Corporation (NYSE: HUN), FMC Corp. (NYSE: FMC) and The Scotts Miracle-Gro Company (NYSE: SMG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3424-100free.

--
Monsanto Co. Analyst Notes
On May 28, 2014, Monsanto Co. (Monsanto) announced the appointment of Marcos Lutz, CEO of Cosan SA and Director of Cosan Ltd., to the Company's Board of Directors with immediate effect. The Company added that Lutz's appointment brings the number of directors in Monsanto's Board to 13. The Company informed that Mr. Lutz will serve on Science and Technology committees and Sustainability and Corporate Responsibility committees, and he will also be up for election at the 2015 annual meeting of shareholders. "On behalf of Monsanto, I am pleased to welcome Marcos Lutz as an independent director to our board," said Hugh Grant, Monsanto's Chairman of the board and CEO. "Marcos' leadership of a diversified global business, his expertise in sustainability and renewable fuels, and experience in Brazil - our company's second largest market following the United States - will bring valuable insight to our board and serve Monsanto well as we work to continue to grow in Brazil and around the world." The full analyst notes on Monsanto are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/MON/report.pdf

--
CF Industries Holdings, Inc. Analyst Notes
On June 3, 2014, CF Industries Holdings, Inc.'s (CF Industries) stock declined 0.02%, ending the day at $244.44. Over the previous three trading sessions, shares in CF Industries rose 0.87%, compared to the Dow Jones industrial average which climbed 0.14% during the same period. The full analyst notes on CF Industries are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/CF/report.pdf

--
Huntsman Corporation Analyst Notes
On May 28, 2014, Huntsman Corporation (Huntsman) announced its plans to privately offer €100.0 million in aggregate principal amount of additional 5.125% senior notes due 2021 (the Notes) via Huntsman International LLC (the Issuer), its wholly-owned subsidiary. According to the Company, the Notes are being offered as additional notes under the indenture, dated as of December 23, 2013, among the Issuer, the guarantors party thereto, Wilmington Trust, National Association, as trustee, and Citibank, N.A., London Branch, as paying agent, transfer agent, registrar and authenticating agent, pursuant to which the Issuer previously issued €300.0 million in aggregate principal amount of its 5.125% senior notes due 2021 on December 23, 2013 (the Initial Notes). Huntsman stated that the Notes will be treated as a single series with, and will have the same terms as, the Initial Notes. Huntsman informed that the net proceeds from the proposed offering is expected to be utilized by the Company for general corporate purposes. The full analyst notes on Huntsman are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/HUN/report.pdf

--
FMC Corp. Analyst Notes
On June 3, 2014, FMC Corp. (FMC) announced that the American Chemistry Council (ACC) has recognized the Company in three categories at the 2014 Responsible Care Conference and Expo which was held in May 2014. FMC received the Responsible Care Performance Award, Responsible Care Facility Safety Award, and Responsible Care Energy Efficiency Award. According to the Company, FMC also earned an award from the Industrial Minerals Association-North America (IMA-NA) at the association's annual meeting, also held in May. The full analyst notes on FMC are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/FMC/report.pdf

--
The Scotts Miracle-Gro Company Analyst Notes
On May 5, 2014, The Scotts Miracle-Gro Company (The Scotts Miracle-Gro) reported its financial results for Q2 FY 2014 (period ended March 29, 2014). The Company's net sales grew 7.3% YoY to $1.1 billion, driven by a strong initial sell-in to retailers. Net income was $125.7 million or $2.00 per diluted share, compared to $100.0 million or $1.60 per diluted share in Q2 FY 2013. "It should come as no surprise that consumer activity was lighter than we had originally anticipated, but we have seen high levels of consumer purchases when the weather has cooperated," said Jim Hagedorn, Chairman and CEO. "We are pleased with the strong support we are seeing from our retail partners and glad to see a strong start to the season in Europe, where our business is currently trending ahead of our internal expectations." He added, "We remain optimistic about our prospects this season and continue to expect adjusted earnings per share of $3.05 to $3.20 for the full year." The full analyst notes on The Scotts Miracle-Gro are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/SMG/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review